mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.7 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.8 |
mRNA |
GDC-0449 |
FIMM |
pan-cancer |
AAC |
0.085 |
0.8 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |